-
Sarcoma survivor on overcoming diagnosis
20 Oct 2025 20:56 GMT
-
Lirum Therapeutics Announces FDA “Study May Proceed” Letter Enabling Inclusion of LX-101 in the RAPID Platform Clinical Trial for Ewing Sarcoma and Desmoplastic Small Round Cell Tumor
20 Oct 2025 20:20 GMT
… with relapsed/refractory Ewing Sarcoma (ES) or desmoplastic small round …
-
Primary Endpoint Met in EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma and Data Presented at ESMO Congress 2025
20 Oct 2025 12:01 GMT
… setting for resectable soft tissue sarcoma (STS) met the … in resectable soft tissue sarcoma. These outcomes achieved in … carcinoma (HNSCC), soft tissue sarcoma, and breast cancer. Its … Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European …
-
New Insights Reveal How Ewing Sarcoma Responds to Chemotherapy
16 Oct 2025 18:38 GMT
… complex and devastating as Ewing sarcoma, enhancing treatment precision could … : Molecular mechanisms underlying Ewing sarcoma’s sensitivity to chemotherapy, … childhood cancerschimeric oncoprotein EWS::FLI1Ewing sarcoma chemotherapy responseEWSR1 FLI1 gene …
-
Uncovering a molecular weakness in Ewing sarcoma for targeted therapy
16 Oct 2025 14:05 GMT
… high sensitivity of Ewing sarcoma (an aggressive bone cancer … specific vulnerability in Ewing sarcoma that can be exploited … some patients with Ewing sarcoma respond particularly well to … -DHX9 interaction promotes Ewing sarcoma sensitivity to DNA topoisomerase …
-
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
21 Oct 2025 14:04 GMT
… myeloid leukemia and soft tissue sarcoma lung metastases. This Canadian patent … Drug Designation for soft tissue sarcoma lung metastases from both the …
-
‘Holy grail’ cancer blood test in NHS trials shows ‘84% accuracy’ in ‘exciting’ results
21 Oct 2025 13:17 GMT
… as bone and soft tissue sarcoma and a type of brain …
-
6 Indian pathologists, scientists shine in Stanford University 2025 Top 2% Scientists List
21 Oct 2025 08:09 GMT
… pathology course, Singapore, 2019 and sarcoma preceptorship course, Singapore.
He was …
-
SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology
21 Oct 2025 06:00 GMT
… .Ed., Associate Professor, Department of Sarcoma Medical Oncology, Division of Cancer … (NCCN Guidelines®) for Soft Tissue Sarcoma V.2.2023. © National Comprehensive …
-
SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology
21 Oct 2025 06:00 GMT
… .Ed., Associate Professor, Department of Sarcoma Medical Oncology, Division of Cancer … (NCCN Guidelines®) for Soft Tissue Sarcoma V.2.2023. © National Comprehensive …